Crossmark

Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-015-4440-4

Published Online: 2015-02-18

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miyazaki, Tatsuya

Ojima, Hitoshi

Fukuchi, Minoru

Sakai, Makoto

Sohda, Makoto

Tanaka, Naritaka

Suzuki, Shigemasa

Ieta, Keisuke

Saito, Kana

Sano, Akihiko

Yokobori, Takehiko

Inose, Takanori

Nakajima, Masanobu

Kato, Hiroyuki

Kuwano, Hiroyuki
License Information

Text and Data Mining valid from 2015-02-18